SHANK1 (Q9Y566) variants and mutations
SHANK1 (also known as Q9Y566) is a human protein-coding gene encoding a SH3 and multiple ankyrin repeat domains protein 1 protein. It organizes postsynaptic protein networks at excitatory synapses and links glutamate receptors to signaling and cytoskeletal machinery. Rare disruptive variants have been associated with neurodevelopmental and psychiatric phenotypes, although penetrance and causal evidence vary. This analysis covers 2,966 SHANK1 variants and mutations. Of these, 97% have computational variant effect predictions. Disease context includes Intellectual disability, neurodevelopmental disorder, and autism. Example SHANK1 variants include H3Q, H3R, and S4I.
Variant analysis overview
- Gene: SHANK1
- Protein: Q9Y566
- UniProt accession: Q9Y566
- Organism: Homo sapiens
- Variants analyzed: 2966
- Variant scope: all variants
- Completed: 2026-08-19
Variant and mutation evidence
- Variant composition: 2,497 unspecified-consequence records; 182 synonymous variants; 250 missense variants; 14 frameshift variants; 5 in-frame deletions; 13 stop-gained variants; 3 in-frame insertions; 1 splice-region variants; 1 substitution
- Prediction scores: 2,864 variants have prediction scores (97% of the analyzed set).
Clinical, disease, and population context
- Disease context: 25 disease associations are represented. Top associations: Intellectual disability, neurodevelopmental disorder, autism, hereditary disease, complex neurodevelopmental disorder, alcohol drinking, Hearing impairment, multiple congenital anomalies/dysmorphic syndrome, non-small cell lung carcinoma, early-onset non-syndromic cataract, B-cell chronic lymphocytic leukemia, Posterior polar cataract.
Protein structure and variant hotspots
- Protein features: 3 domains; 18 post-translational modification sites.
- Structural context: 279 variants have structural context.
- PTM context: 37 variants overlap post-translational modification sites.
Data sources
Evidence in this analysis draws on EBI Proteins Variation, UniProt, gnomAD v4, EuropePMC, 3D Hotspot Analysis, Interaction Network Analysis, AlphaFold DB, gnomAD constraint, Open Targets, ClinGen, MaveDB, LitVar.
Notable SHANK1 variants
Examples include H3Q, H3R, S4I, P5T, A6P, A6S, A6T, A6V. Listed records include available protein-change notation, database identifiers, clinical classifications, computational predictions, population evidence, experimental measurements, and disease context.
- H3Q (p.His3Gln), gnomAD rs1364976025, REVEL 0.08, MetaLR 0.04
- H3R (p.His3Arg), TOPMed rs926922293, REVEL 0.08, MetaLR 0.03
- S4I (p.Ser4Ile), cosmic curated COSV10512, gnomAD rs1273864257, REVEL 0.19, MetaLR 0.16
- P5T (p.Pro5Thr), gnomAD rs1405250162, REVEL 0.19, MetaLR 0.12
- A6P (p.Ala6Pro), ESP rs374708018, ExAC rs374708018, TOPMed rs374708018, gnomAD rs374708018, Likely benign
- A6S (p.Ala6Ser), ESP rs374708018, ExAC rs374708018, TOPMed rs374708018, gnomAD rs374708018, REVEL 0.08, MetaLR 0.05, Likely benign
- A6T (p.Ala6Thr), rs374708018, ClinGen CA9602267, ClinVar RCV002674834, ESP rs374708018, REVEL 0.14, MetaLR 0.03, Likely benign, Inborn genetic diseases
- A6V (p.Ala6Val), rs10423744, cosmic curated COSV53247, UniProt VAR 055318, ExAC rs10423744, REVEL 0.12, MetaLR 0.03
- S8T (p.Ser8Thr), Ensembl rs2089077182, MetaLR 0.09, MetaSVM -0.96
- E9K (p.Glu9Lys), cosmic curated COSV53253, Ensembl rs2089077095, REVEL 0.13, MetaLR 0.07
- E9V (p.Glu9Val), ExAC rs775904234, gnomAD rs775904234, REVEL 0.16, MetaLR 0.06
- E11K (p.Glu11Lys), NCI-TCGA Cosmic COSV5324, cosmic curated COSV53244, NCI-TCGA Cosmic COSV5326, TOPMed rs2089076990, REVEL 0.21, MetaLR 0.16, Variant assessed as somatic; moderate impact.
- E12K (p.Glu12Lys), TOPMed rs1200412558, gnomAD rs1200412558, REVEL 0.11, MetaLR 0.07
- R13C (p.Arg13Cys), cosmic curated COSV53252, ExAC rs767848654, TOPMed rs767848654, gnomAD rs767848654, REVEL 0.17, MetaLR 0.06
- R13G (p.Arg13Gly), ExAC rs767848654, TOPMed rs767848654, gnomAD rs767848654, REVEL 0.09, MetaLR 0.04
- R13H (p.Arg13His), cosmic curated COSV53262, 1000Genomes rs530590955, ExAC rs530590955, TOPMed rs530590955, REVEL 0.02, MetaLR 0.04
- R13P (p.Arg13Pro), 1000Genomes rs530590955, ExAC rs530590955, TOPMed rs530590955, gnomAD rs530590955, MetaLR 0.05, MetaSVM -1.04
- H14R (p.His14Arg), Ensembl rs865840319, REVEL 0.10, MetaLR 0.03
- H14Y (p.His14Tyr), TOPMed rs2089076746, REVEL 0.13, MetaLR 0.05, Uncertain significance, Inborn genetic diseases
- S15T (p.Ser15Thr), rs2513973511, ClinGen CA406999334, ClinVar RCV003357565, REVEL 0.05, MetaLR 0.10, Uncertain significance, Inborn genetic diseases
- A16T (p.Ala16Thr), Ensembl rs2089076704, REVEL 0.03, MetaLR 0.05
- E18K (p.Glu18Lys), rs200002234, ExAC rs200002234, TOPMed rs200002234, gnomAD rs200002234, REVEL 0.09, MetaLR 0.04, Variant assessed as somatic; moderate impact.
- E18Q (p.Glu18Gln), rs200002234, ClinGen CA406999264, ClinVar RCV003261429, REVEL 0.03, MetaLR 0.05, Uncertain significance, Inborn genetic diseases
- P20R (p.Pro20Arg), TOPMed rs1477523945, gnomAD rs1477523945, REVEL 0.14, MetaLR 0.06
- P20T (p.Pro20Thr), ESP rs201688212, ExAC rs201688212, TOPMed rs201688212, gnomAD rs201688212, REVEL 0.10, MetaLR 0.05, Likely benign, Inborn genetic diseases
- E21K (p.Glu21Lys), cosmic curated COSV53259, ESP rs372307194, ExAC rs372307194, TOPMed rs372307194, REVEL 0.11, MetaLR 0.06, Uncertain significance, Inborn genetic diseases
- G22E (p.Gly22Glu), ExAC rs779915796, gnomAD rs779915796, REVEL 0.21, MetaLR 0.04
- G22R (p.Gly22Arg), cosmic curated COSV99035, ExAC rs746931414, gnomAD rs746931414, REVEL 0.20, MetaLR 0.13
- G22W (p.Gly22Trp), ExAC rs746931414, gnomAD rs746931414, REVEL 0.23, MetaLR 0.15
- G23A (p.Gly23Ala), NCI-TCGA TCGA novel, MetaLR 0.05, MetaSVM -1.08, Variant assessed as somatic; high impact.
- G23D (p.Gly23Asp), TOPMed rs879093481, gnomAD rs879093481, REVEL 0.23, MetaLR 0.04, Uncertain significance, Inborn genetic diseases
- G23V (p.Gly23Val), TOPMed rs879093481, gnomAD rs879093481, REVEL 0.13, MetaLR 0.04, Uncertain significance
- S24L (p.Ser24Leu), NCI-TCGA TCGA novel, Ensembl rs2123209455, REVEL 0.07, MetaLR 0.07, Variant assessed as somatic; moderate impact.
- S24P (p.Ser24Pro), cosmic curated COSV53252, Ensembl rs2123209463, REVEL 0.07, MetaLR 0.09
- E25* (p.Glu25Ter), NCI-TCGA Cosmic COSV5326, cosmic curated COSV53260, Variant assessed as somatic; high impact.
- E25G (p.Glu25Gly), TOPMed rs2051257237, REVEL 0.06, MetaLR 0.07
- E25K (p.Glu25Lys), TOPMed rs2089076251, REVEL 0.08, MetaLR 0.06
- E25Q (p.Glu25Gln), NCI-TCGA Cosmic COSV5326, MetaLR 0.04, MetaSVM -1.02, Variant assessed as somatic; moderate impact.
- S26F (p.Ser26Phe), cosmic curated COSV10512, ExAC rs758265167, gnomAD rs758265167, REVEL 0.18, MetaLR 0.15
- D27E (p.Asp27Glu), ExAC rs779220124, TOPMed rs779220124, gnomAD rs779220124, REVEL 0.03, MetaLR 0.07
- D27N (p.Asp27Asn), cosmic curated COSV10512, 1000Genomes rs533410806, ExAC rs533410806, TOPMed rs533410806, REVEL 0.07, MetaLR 0.08
- D27Y (p.Asp27Tyr), 1000Genomes rs533410806, ExAC rs533410806, TOPMed rs533410806, gnomAD rs533410806, REVEL 0.20, MetaLR 0.14
- S28I (p.Ser28Ile), TOPMed rs962501428, gnomAD rs962501428, REVEL 0.16, MetaLR 0.17
- S28T (p.Ser28Thr), TOPMed rs962501428, gnomAD rs962501428, MetaLR 0.09, MetaSVM -0.92
- S29F (p.Ser29Phe), cosmic curated COSV10880, Ensembl rs2089075938, MetaLR 0.16, MetaSVM -0.73
- S29P (p.Ser29Pro), ExAC rs757580347, TOPMed rs757580347, gnomAD rs757580347, REVEL 0.11, MetaLR 0.15
- P30S (p.Pro30Ser), NCI-TCGA Cosmic COSV5324, cosmic curated COSV53244, REVEL 0.04, MetaLR 0.04, Variant assessed as somatic; moderate impact.
- D31A (p.Asp31Ala), ExAC rs753824429, TOPMed rs753824429, gnomAD rs753824429, REVEL 0.04, MetaLR 0.05, Uncertain significance
- D31E (p.Asp31Glu), NCI-TCGA Cosmic COSV9952, cosmic curated COSV99520, REVEL 0.03, MetaLR 0.03, Variant assessed as somatic; moderate impact.
- D31G (p.Asp31Gly), rs753824429, ClinGen CA406999018, ClinVar RCV003358944, ExAC rs753824429, REVEL 0.06, MetaLR 0.05, Uncertain significance, Inborn genetic diseases
- G32E (p.Gly32Glu), cosmic curated COSV10880, TOPMed rs2089075812, gnomAD rs2089075812, REVEL 0.10, MetaLR 0.03
- G32R (p.Gly32Arg), rs756200161, NCI-TCGA Cosmic COSV9952, cosmic curated COSV99522, ExAC rs756200161, REVEL 0.14, MetaLR 0.07, Variant assessed as somatic; moderate impact.
- P33S (p.Pro33Ser), gnomAD rs1192965719, REVEL 0.09, MetaLR 0.05
- P33T (p.Pro33Thr), NCI-TCGA Cosmic COSV9951, cosmic curated COSV99519, REVEL 0.09, MetaLR 0.04, Variant assessed as somatic; moderate impact.
- G34C (p.Gly34Cys), TOPMed rs1429180159, gnomAD rs1429180159, REVEL 0.08, MetaLR 0.07
- G34D (p.Gly34Asp), rs768176382, ClinGen CA9602246, cosmic curated COSV99035, ClinVar RCV003491474, REVEL 0.07, MetaLR 0.04, Uncertain significance, not provided
- G34S (p.Gly34Ser), TOPMed rs1429180159, gnomAD rs1429180159, REVEL 0.02, MetaLR 0.03
- R35* (p.Arg35Ter), rs267605598, ClinVar RCV006452131, gnomAD rs267605598, CADD 33.00, Uncertain significance
- R35L (p.Arg35Leu), ESP rs368372946, ExAC rs368372946, TOPMed rs368372946, gnomAD rs368372946, REVEL 0.02, MetaLR 0.04
- R35P (p.Arg35Pro), ESP rs368372946, ExAC rs368372946, TOPMed rs368372946, gnomAD rs368372946, REVEL 0.07, MetaLR 0.04
- R35Q (p.Arg35Gln), ESP rs368372946, ExAC rs368372946, TOPMed rs368372946, gnomAD rs368372946, REVEL 0.01, MetaLR 0.04
- P37H (p.Pro37His), gnomAD rs1262222366, REVEL 0.10, MetaLR 0.05
- R38P (p.Arg38Pro), ExAC rs764819969, TOPMed rs764819969, REVEL 0.15, MetaLR 0.06
- R38Q (p.Arg38Gln), cosmic curated COSV53249, ExAC rs764819969, TOPMed rs764819969, REVEL 0.04, MetaLR 0.04
- R38W (p.Arg38Trp), ExAC rs774708596, TOPMed rs774708596, gnomAD rs774708596, REVEL 0.13, MetaLR 0.05
- G39E (p.Gly39Glu), ExAC rs761557772, gnomAD rs761557772, REVEL 0.26, MetaLR 0.04
- G39R (p.Gly39Arg), TOPMed rs1225349738, NCI-TCGA Cosmic COSV9952, cosmic curated COSV99521, Variant assessed as somatic; moderate impact.
- G39V (p.Gly39Val), ExAC rs761557772, gnomAD rs761557772, REVEL 0.21, MetaLR 0.10
- T40A (p.Thr40Ala), TOPMed rs1307563282, gnomAD rs1307563282, REVEL 0.04, MetaLR 0.03
- R41Q (p.Arg41Gln), rs558942714, ClinGen CA9602236, ClinVar RCV001658894, 1000Genomes rs558942714, REVEL 0.13, MetaLR 0.08, Uncertain significance, not provided
- R41W (p.Arg41Trp), cosmic curated COSV99522, ExAC rs746568579, gnomAD rs746568579, REVEL 0.23, MetaLR 0.12
- G42A (p.Gly42Ala), TOPMed rs1337761678, gnomAD rs1337761678, REVEL 0.18, MetaLR 0.05
- G42D (p.Gly42Asp), TOPMed rs1337761678, gnomAD rs1337761678, REVEL 0.23, MetaLR 0.12
- Q43E (p.Gln43Glu), ESP rs369231585, ExAC rs369231585, gnomAD rs369231585
- G44D (p.Gly44Asp), gnomAD rs1462720685, REVEL 0.25, MetaLR 0.04
- G44V (p.Gly44Val), NCI-TCGA Cosmic COSV5326, cosmic curated COSV53260, MetaLR 0.05, MetaSVM -1.00, Variant assessed as somatic; moderate impact.
- S45I (p.Ser45Ile), rs1243508395, ClinGen CA406998764, ClinVar RCV002960057, Ensembl rs1243508395, REVEL 0.14, MetaLR 0.06, Uncertain significance, Inborn genetic diseases
- G46W (p.Gly46Trp), NCI-TCGA Cosmic COSV9952, cosmic curated COSV99522, Variant assessed as somatic; moderate impact.
- A47S (p.Ala47Ser), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- A47T (p.Ala47Thr), TOPMed rs1162796795, gnomAD rs1162796795, REVEL 0.01, MetaLR 0.06, Uncertain significance, Inborn genetic diseases
- P48A (p.Pro48Ala), ExAC rs777918685, TOPMed rs777918685, gnomAD rs777918685, REVEL 0.05, MetaLR 0.04
- P48H (p.Pro48His), NCI-TCGA Cosmic COSV9952, cosmic curated COSV99521, MetaLR 0.07, MetaSVM -1.03, Variant assessed as somatic; moderate impact.
- P48R (p.Pro48Arg), ExAC rs756211849, gnomAD rs756211849, REVEL 0.15, MetaLR 0.05
- P48S (p.Pro48Ser), cosmic curated COSV10880, ExAC rs777918685, TOPMed rs777918685, gnomAD rs777918685, REVEL 0.05, MetaLR 0.04
- G49C (p.Gly49Cys), ExAC rs752720674, TOPMed rs752720674, gnomAD rs752720674, REVEL 0.20, MetaLR 0.09
- G49R (p.Gly49Arg), ExAC rs752720674, TOPMed rs752720674, gnomAD rs752720674, REVEL 0.16, MetaLR 0.06
- S50N (p.Ser50Asn), Ensembl rs2089074439, REVEL 0.07, MetaLR 0.04
- S50R (p.Ser50Arg), ExAC rs767950625, TOPMed rs767950625, gnomAD rs767950625, REVEL 0.05, MetaLR 0.06
- S53F (p.Ser53Phe), rs2513973102, ClinGen CA406998596, ClinVar RCV002281259, REVEL 0.20, MetaLR 0.08, Uncertain significance, not provided
- V54I (p.Val54Ile), ExAC rs751880773, gnomAD rs751880773, REVEL 0.02, MetaLR 0.04
- G56C (p.Gly56Cys), 1000Genomes rs201399581, ExAC rs201399581, gnomAD rs201399581, REVEL 0.18, MetaLR 0.07
- G56D (p.Gly56Asp), gnomAD rs1248881476, REVEL 0.14, MetaLR 0.06
- L57F (p.Leu57Phe), NCI-TCGA Cosmic COSV5326, Variant assessed as somatic; moderate impact.
- L57I (p.Leu57Ile), NCI-TCGA Cosmic COSV5326, cosmic curated COSV53260, Variant assessed as somatic; moderate impact.
- Q58* (p.Gln58Ter), gnomAD rs1411968026, CADD 36.00
- G59D (p.Gly59Asp), cosmic curated COSV10735, ExAC rs763275118, gnomAD rs763275118, REVEL 0.12, MetaLR 0.05
- R60C (p.Arg60Cys), cosmic curated COSV53255, ExAC rs753526209, TOPMed rs753526209, gnomAD rs753526209, REVEL 0.24, MetaLR 0.11, Uncertain significance, Inborn genetic diseases
- R60H (p.Arg60His), rs376765376, cosmic curated COSV99522, ESP rs376765376, ExAC rs376765376, REVEL 0.16, MetaLR 0.06, Variant assessed as somatic; moderate impact.
- R60L (p.Arg60Leu), ESP rs376765376, ExAC rs376765376, TOPMed rs376765376, gnomAD rs376765376, REVEL 0.22, MetaLR 0.07
- M62I (p.Met62Ile), gnomAD rs2089073957, REVEL 0.04, MetaLR 0.05
- M62V (p.Met62Val), TOPMed rs1020603187, gnomAD rs1020603187, REVEL 0.05, MetaLR 0.05
- S63T (p.Ser63Thr), NCI-TCGA TCGA novel, REVEL 0.02, MetaLR 0.04, Variant assessed as somatic; moderate impact.
- V64A (p.Val64Ala), NCI-TCGA Cosmic COSV5324, cosmic curated COSV53249, REVEL 0.08, MetaLR 0.06, Variant assessed as somatic; moderate impact.
- V64F (p.Val64Phe), ExAC rs774877899, TOPMed rs774877899, gnomAD rs774877899, REVEL 0.21, MetaLR 0.15
- V64I (p.Val64Ile), cosmic curated COSV53257, ExAC rs774877899, TOPMed rs774877899, gnomAD rs774877899, REVEL 0.10, MetaLR 0.10
- P65L (p.Pro65Leu), ExAC rs772098608, gnomAD rs772098608, REVEL 0.13, MetaLR 0.10
- D66E (p.Asp66Glu), 1000Genomes rs545121253, ExAC rs545121253, TOPMed rs545121253, gnomAD rs545121253, REVEL 0.07, MetaLR 0.03
- D66G (p.Asp66Gly), Ensembl rs563250952, REVEL 0.16, MetaLR 0.08
- D66V (p.Asp66Val), NCI-TCGA Cosmic COSV9952, cosmic curated COSV99521, MetaLR 0.10, MetaSVM -1.01, Variant assessed as somatic; moderate impact.
- D67A (p.Asp67Ala), TOPMed rs1378230346, gnomAD rs1378230346, REVEL 0.07, MetaLR 0.10
- D67H (p.Asp67His), NCI-TCGA Cosmic COSV1043, NCI-TCGA Cosmic COSV9952, cosmic curated COSV99522, REVEL 0.20, MetaLR 0.25, Variant assessed as somatic; moderate impact.
- D67N (p.Asp67Asn), rs372491377, ClinGen CA309619656, cosmic curated COSV10439, ClinVar RCV002683453, REVEL 0.19, MetaLR 0.17, Uncertain significance, Inborn genetic diseases
- A68D (p.Ala68Asp), Ensembl rs2089073520, REVEL 0.22, MetaLR 0.12
- A68P (p.Ala68Pro), ESP rs150390491, ExAC rs150390491, TOPMed rs150390491, gnomAD rs150390491
- A68T (p.Ala68Thr), rs150390491, cosmic curated COSV53264, ESP rs150390491, ExAC rs150390491, REVEL 0.10, MetaLR 0.04, Variant assessed as somatic; moderate impact.
- S71I (p.Ser71Ile), gnomAD rs1207754858, REVEL 0.39, MetaLR 0.14
- S71N (p.Ser71Asn), rs1207754858, NCI-TCGA Cosmic COSV5326, cosmic curated COSV53262, gnomAD rs1207754858, Variant assessed as somatic; moderate impact.
- M72V (p.Met72Val), rs2513972945, ClinGen CA406998156, ClinVar RCV004450857, Uncertain significance, Inborn genetic diseases
- M73T (p.Met73Thr), ExAC rs749101925, gnomAD rs749101925, REVEL 0.30, MetaLR 0.08
- I77T (p.Ile77Thr), gnomAD rs1252376884, REVEL 0.31, MetaLR 0.22
- G78D (p.Gly78Asp), Ensembl rs2089073325, REVEL 0.28, MetaLR 0.22
- P80L (p.Pro80Leu), cosmic curated COSV10735, Ensembl rs2089073257, REVEL 0.26, MetaLR 0.27, Uncertain significance, not provided
- Q84H (p.Gln84His), NCI-TCGA Cosmic COSV9952, cosmic curated COSV99520, Variant assessed as somatic; moderate impact.
- L88F (p.Leu88Phe), NCI-TCGA Cosmic COSV5325, cosmic curated COSV53252, Variant assessed as somatic; moderate impact.
- R89C (p.Arg89Cys), rs1183898203, NCI-TCGA Cosmic COSV9952, cosmic curated COSV99521, TOPMed rs1183898203, REVEL 0.28, MetaLR 0.12, Variant assessed as somatic; moderate impact.
- F90L (p.Phe90Leu), ExAC rs748338051, gnomAD rs748338051, REVEL 0.19, MetaLR 0.07
- D93G (p.Asp93Gly), NCI-TCGA Cosmic COSV5324, cosmic curated COSV53249, MetaLR 0.09, MetaSVM -1.03, Variant assessed as somatic; moderate impact.
- D93N (p.Asp93Asn), rs768707641, NCI-TCGA Cosmic COSV5324, cosmic curated COSV53246, ExAC rs768707641, REVEL 0.12, MetaLR 0.04, Variant assessed as somatic; moderate impact.
- A94V (p.Ala94Val), NCI-TCGA Cosmic COSV9952, cosmic curated COSV99521, MetaLR 0.10, MetaSVM -1.01, Variant assessed as somatic; moderate impact.
- T95A (p.Thr95Ala), NCI-TCGA Cosmic COSV9952, cosmic curated COSV99521, Variant assessed as somatic; moderate impact.
- T95P (p.Thr95Pro), Ensembl rs1599875629
- I96T (p.Ile96Thr), NCI-TCGA Cosmic COSV5325, cosmic curated COSV53257, MetaLR 0.04, MetaSVM -1.09, Variant assessed as somatic; moderate impact.
- I96V (p.Ile96Val), TOPMed rs1158453778, gnomAD rs1158453778, REVEL 0.05, MetaLR 0.01
- W97* (p.Trp97Ter), gnomAD rs2089070501, CADD 37.00
- T98K (p.Thr98Lys), NCI-TCGA TCGA novel, MetaLR 0.02, MetaSVM -0.94, Variant assessed as somatic; moderate impact.
- T98M (p.Thr98Met), 1000Genomes rs143340442, ESP rs143340442, ExAC rs143340442, TOPMed rs143340442, REVEL 0.13, MetaLR 0.02, Likely benign, Inborn genetic diseases
- L104F (p.Leu104Phe), cosmic curated COSV53244, gnomAD rs2089070348, REVEL 0.23, MetaLR 0.09
- C105S (p.Cys105Ser), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- A106T (p.Ala106Thr), NCI-TCGA Cosmic COSV5326, cosmic curated COSV53260, Variant assessed as somatic; moderate impact.
- L107R (p.Leu107Arg), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- S108N (p.Ser108Asn), ExAC rs779119326, gnomAD rs779119326, REVEL 0.07, MetaLR 0.01
- E109D (p.Glu109Asp), TOPMed rs1431321665, gnomAD rs1431321665, REVEL 0.10, MetaLR 0.06
- E109K (p.Glu109Lys), rs752386801, ClinGen CA9602185, ClinVar RCV003271723, ExAC rs752386801, REVEL 0.16, MetaLR 0.04, Uncertain significance, Inborn genetic diseases
- E109Q (p.Glu109Gln), NCI-TCGA Cosmic COSV9952, cosmic curated COSV99520, REVEL 0.12, MetaLR 0.03, Variant assessed as somatic; moderate impact.
- L115V (p.Leu115Val), Ensembl rs1568446875
- P122L (p.Pro122Leu), ExAC rs767347935, TOPMed rs767347935, gnomAD rs767347935, REVEL 0.28, MetaLR 0.12
- P122T (p.Pro122Thr), NCI-TCGA Cosmic COSV5325, cosmic curated COSV53254, Variant assessed as somatic; moderate impact.
- T124A (p.Thr124Ala), rs751125503, ClinGen CA406997058, ClinVar RCV004450862, ExAC rs751125503, Uncertain significance, Inborn genetic diseases
- T124P (p.Thr124Pro), ExAC rs751125503, TOPMed rs751125503, gnomAD rs751125503, Uncertain significance
- T124S (p.Thr124Ser), rs751125503, ClinGen CA9602182, ClinVar RCV002595275, ClinVar RCV004961083, REVEL 0.07, MetaLR 0.02, Uncertain significance, not provided; Inborn genetic diseases
- S125Y (p.Ser125Tyr), NCI-TCGA TCGA novel, MetaLR 0.03, MetaSVM -1.06, Variant assessed as somatic; moderate impact.
- G126C (p.Gly126Cys), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- R127C (p.Arg127Cys), cosmic curated COSV53263, ExAC rs766287221, TOPMed rs766287221, gnomAD rs766287221, REVEL 0.31, MetaLR 0.11
- R127H (p.Arg127His), rs539761857, 1000Genomes rs539761857, ExAC rs539761857, TOPMed rs539761857, REVEL 0.16, MetaLR 0.04, Variant assessed as somatic; moderate impact.
- D128N (p.Asp128Asn), rs761652968, NCI-TCGA Cosmic COSV9952, cosmic curated COSV99521, ExAC rs761652968, REVEL 0.20, MetaLR 0.09, Variant assessed as somatic; moderate impact.
- D128Y (p.Asp128Tyr), NCI-TCGA Cosmic COSV9952, Variant assessed as somatic; moderate impact.
- A129D (p.Ala129Asp), NCI-TCGA TCGA novel, MetaLR 0.08, MetaSVM -1.10, Variant assessed as somatic; moderate impact.
- L137P (p.Leu137Pro), ExAC rs747043906, gnomAD rs747043906, REVEL 0.21, MetaLR 0.04
- R139Q (p.Arg139Gln), cosmic curated COSV10453, gnomAD rs1756532215, REVEL 0.19, MetaLR 0.08
- Q143P (p.Gln143Pro), rs1599875550, ClinGen CA406996845, ClinVar RCV003312455, Ensembl rs1599875550, Uncertain significance, not provided
- E146K (p.Glu146Lys), Ensembl rs2123207834
- E146Q (p.Glu146Gln), NCI-TCGA Cosmic COSV5324, cosmic curated COSV53247, MetaLR 0.04, MetaSVM -1.04, Variant assessed as somatic; moderate impact.
- V149G (p.Val149Gly), Ensembl rs1599875548, MetaLR 0.13, MetaSVM -0.91
- P150S (p.Pro150Ser), NCI-TCGA Cosmic COSV5325, cosmic curated COSV53258, REVEL 0.37, MetaLR 0.10, Variant assessed as somatic; moderate impact.
- Y151F (p.Tyr151Phe), ExAC rs775464318, gnomAD rs775464318, MetaLR 0.07, MetaSVM -1.10
- F154=, NCI-TCGA Cosmic COSV5324, Variant assessed as somatic; low impact.
- F154L (p.Phe154Leu), NCI-TCGA Cosmic COSV5324, REVEL 0.19, MetaLR 0.05, Variant assessed as somatic; moderate impact.
- R155Q (p.Arg155Gln), rs764261626, NCI-TCGA Cosmic COSV5325, cosmic curated COSV53255, ExAC rs764261626, Variant assessed as somatic; moderate impact.
- Y156H (p.Tyr156His), rs2513971485, ClinGen CA406995006, ClinVar RCV003223824, Uncertain significance, not provided
- K162R (p.Lys162Arg), ExAC rs746029352, gnomAD rs746029352, REVEL 0.07, MetaLR 0.04
- Q163E (p.Gln163Glu), Ensembl rs2089061779
- Q163H (p.Gln163His), cosmic curated COSV10963, NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- Q163K (p.Gln163Lys), NCI-TCGA Cosmic COSV9952, cosmic curated COSV99521, Variant assessed as somatic; moderate impact.
- T164I (p.Thr164Ile), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- T164N (p.Thr164Asn), TOPMed rs1182320332, gnomAD rs1182320332, REVEL 0.11, MetaLR 0.05
- T164S (p.Thr164Ser), NCI-TCGA TCGA novel, MetaLR 0.03, MetaSVM -1.01, Variant assessed as somatic; moderate impact.
- N165K (p.Asn165Lys), TOPMed rs2089061661
- N165T (p.Asn165Thr), ExAC rs774658521, gnomAD rs774658521, REVEL 0.14, MetaLR 0.07
- N165Y (p.Asn165Tyr), Ensembl rs2123206673
- D167G (p.Asp167Gly), ExAC rs749616695, gnomAD rs749616695, REVEL 0.23, MetaLR 0.05
Public SHANK1 analysis runs
- SHANK1 analysis run — SHANK1 (2,966 variants) — completed 2026-08-19